Search Results - "Vanden Meerschaut, F"

Refine Results
  1. 1

    GENType: all-in-one preimplantation genetic testing by pedigree haplotyping and copy number profiling suitable for third-party reproduction by De Witte, L, Raman, L, Baetens, M, De Koker, A, Callewaert, N, Symoens, S, Tilleman, K, Vanden Meerschaut, F, Dheedene, A, Menten, B

    Published in Human reproduction (Oxford) (30-06-2022)
    “…Abstract STUDY QUESTION Is it possible to develop a comprehensive pipeline for all-in-one preimplantation genetic testing (PGT), also suitable for parents-only…”
    Get full text
    Journal Article
  2. 2

    Human oocyte calcium analysis predicts the response to assisted oocyte activation in patients experiencing fertilization failure after ICSI by Ferrer-Buitrago, M, Dhaenens, L, Lu, Y, Bonte, D, Vanden Meerschaut, F, De Sutter, P, Leybaert, L, Heindryckx, B

    Published in Human reproduction (Oxford) (01-03-2018)
    “…Abstract STUDY QUESTION Can human oocyte calcium analysis predict fertilization success after assisted oocyte activation (AOA) in patients experiencing…”
    Get full text
    Journal Article
  3. 3

    Assisted oocyte activation overcomes fertilization failure in globozoospermic patients regardless of the DPY19L2 status by Kuentz, P., Vanden Meerschaut, F., ElInati, E., Nasr-Esfahani, M.H., Gurgan, T., Iqbal, N., Carré-Pigeon, F., Brugnon, F., Gitlin, S.A., Velez de la Calle, J., Kilani, Z., De Sutter, P., Viville, S.

    Published in Human reproduction (Oxford) (01-04-2013)
    “…STUDY QUESTION Does DPY19L2 status influence intracytoplasmic sperm injection (ICSI) outcomes with or without assisted oocyte activation (AOA)? SUMMARY ANSWER…”
    Get full text
    Journal Article
  4. 4

    SPERM FACTORS AND EGG ACTIVATION: Fertilization failure after human ICSI and the clinical potential of PLCZ1 by Cardona Barberán, A, Boel, A, Vanden Meerschaut, F, Stoop, D, Heindryckx, B

    Published in Reproduction (Cambridge, England) (23-05-2022)
    “…Two decades have passed since the discovery of phospholipase C zeta (PLCZ1) as the sperm oocyte-activating factor. At present, there is a general consensus…”
    Get full text
    Journal Article
  5. 5

    PCOS in lesbian and heterosexual women treated with artificial donor insemination by De Sutter, P, Dutré, T, Meerschaut, F Vanden, Stuyver, I, Van Maele, G, Dhont, M

    Published in Reproductive biomedicine online (2008)
    “…Abstract It has been claimed that the prevalence of polycystic ovary syndrome (PCOS) is significantly higher in lesbian compared with heterosexual women. The…”
    Get full text
    Journal Article
  6. 6

    Assisted oocyte activation does not overcome recurrent embryo developmental problems by Cardona Barberán, A, Bonte, D, Boel, A, Thys, V, Paredis, R, Machtelinckx, F, De Sutter, P, De Croo, I, Leybaert, L, Stoop, D, Coucke, P, Vanden Meerschaut, F, Heindryckx, B

    Published in Human reproduction (Oxford) (02-05-2023)
    “…Abstract STUDY QUESTION Can recurrent embryo developmental problems after ICSI be overcome by assisted oocyte activation (AOA)? SUMMARY ANSWER AOA did not…”
    Get full text
    Journal Article
  7. 7

    Diagnostic and prognostic value of calcium oscillatory pattern analysis for patients with ICSI fertilization failure by Vanden Meerschaut, F., Leybaert, L., Nikiforaki, D., Qian, C., Heindryckx, B., De Sutter, P.

    Published in Human reproduction (Oxford) (01-01-2013)
    “…STUDY QUESTION Does calcium oscillatory pattern analysis following heterologous intra-cytoplasmic sperm injection (ICSI) of human sperm into mouse oocytes lead…”
    Get full text
    Journal Article
  8. 8

    Impact of ARTs on oncological outcomes in young breast cancer survivors by Condorelli, M, De Vos, M, Lie Fong, S, Autin, C, Delvigne, A, Vanden Meerschaut, F, Wyns, C, Imbert, R, Cheruy, C, Bouziotis, J, de Azambuja, E, Delbaere, A, Lambertini, M, Demeestere, I

    Published in Human reproduction (Oxford) (25-01-2021)
    “…Abstract STUDY QUESTION What is the risk of recurrence in young breast cancer survivors who undergo ARTs following completion of anticancer treatment? SUMMARY…”
    Get full text
    Journal Article
  9. 9

    Assisted oocyte activation is not beneficial for all patients with a suspected oocyte-related activation deficiency by Vanden Meerschaut, F., Nikiforaki, D., De Gheselle, S., Dullaerts, V., Van den Abbeel, E., Gerris, J., Heindryckx, B., De Sutter, P.

    Published in Human reproduction (Oxford) (01-07-2012)
    “…BACKGROUND Despite the success of ICSI, total fertilization failure (TFF) still occurs in 1–3% of all ICSI cycles. ICSI followed by assisted oocyte activation…”
    Get full text
    Journal Article
  10. 10

    Oocyte cryopreservation and in vitro culture affect calcium signalling during human fertilization by Nikiforaki, D., Vanden Meerschaut, F., Qian, C., De Croo, I., Lu, Y., Deroo, T., Van den Abbeel, E., Heindryckx, B., De Sutter, P.

    Published in Human reproduction (Oxford) (01-01-2014)
    “…STUDY QUESTION What are the precise patterns of calcium oscillations during the fertilization of human oocytes matured either in vivo or in vitro or aged in…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    O-230 The ethics of disclosing reported conditions in donor-conceived offspring to recipients of the same donor by Accoe, D, Pennings, G, Janssens, S, Vanden Meerschaut, F, Mertes, H

    Published in Human reproduction (Oxford) (03-07-2024)
    “…Abstract Study question To what extent should new genetic risk information, identified after donation, be disclosed to recipients? Summary answer Withholding…”
    Get full text
    Journal Article
  16. 16

    P-274 Cycles with a high proportion of smooth endoplasmatic reticulum aggregates oocytes have a higher risk of transfer cancellation, but similar clinical outcomes after embryo transfer by Spileers, A, De Croo, I, Degheselle, S, Stoop, D, Vanden Meerschaut, F

    Published in Human reproduction (Oxford) (29-06-2022)
    “…Abstract Study question Are the clinical outcomes of an ICSI cycle impacted by the proportion of oocytes with smooth endoplasmatic reticulum aggregates (SERa)?…”
    Get full text
    Journal Article
  17. 17

    P-740 Monogenic and digenic variants in male PLCZ1, ACTL7A and ACTL9 genes cause fertilization failure after ICSI by Cardona Barberán, A, Boel, A, Colenbier, C, Van der Velden, E, Stoop, D, Coucke, P, Vanden Meerschaut, F, Heindryckx, B

    Published in Human reproduction (Oxford) (22-06-2023)
    “…Abstract Study question What is the frequency of PLCZ1, ACTL7A and ACTL9 variants in male patients suffering from fertilization failure (FF) after ICSI?…”
    Get full text
    Journal Article
  18. 18

    P-672 Is there a sweet spot for follicular size and/or estradiol level for the initiation of micronized progesterone to optimize natural proliferative phase (NPP) cryo-cycle outcome? by Stoop, D, Dhaenens, L, De Croo, I, Vandierendonck, F, Heindyckx, B, Tilleman, K, De Roo, C, Vanden Meerschaut, F, Rottiers, A  S

    Published in Human reproduction (Oxford) (03-07-2024)
    “…Abstract Study question Is there an optimal follicular size and/or estradiol level for the initiation of micronized progesterone to optimize outcomes in NPP…”
    Get full text
    Journal Article
  19. 19
  20. 20

    P-429 Measuring serum progesterone levels on the day of a fresh blastocyst transfer is debatable as there is no evidence for correlation with ongoing pregnancy results by Rottiers, A  S, De Roo, C, Vandierendonck, F, Heindryckx, B, Tilleman, K, De Croo, I, Vanden Meerschaut, F, Dhaenens, L, Stoop, D

    Published in Human reproduction (Oxford) (03-07-2024)
    “…Abstract Study question Does serum progesterone (P4) level on the day of a fresh blastocyst transfer relate to ongoing pregnancy rate (OPR)? Summary answer OPR…”
    Get full text
    Journal Article